(845) 986-2777
24 Main Street, Warwick, NY 10990
(212) 203-7710
450 7th Avenue, 33rd Fl, New York, NY 10123

Zimmer Biomet News: M2a Magnum Hip Implant / NexGen Knee Implant / Durom Hip Cup / Products Liability Multidistrict Litigation (MDL) & Comprehensive Reverse Shoulder System Humeral Tray Model 115340 Recall

Zimmer Biomet News: M2a Magnum Hip Implant / NexGen Knee Implant / Durom Hip Cup / Products Liability Multidistrict Litigation (MDL) & Comprehensive Reverse Shoulder System Humeral Tray Model 115340 Recall


For more information, please contact The Ahearne Law Firm, PLLC for an initial consultation and case evaluation. Call nationwide at (845) 986-2777.

The following is the status of pending multidistrict litigation (MDL) and defective product recalls by major orthopedic medical device manufacturer, Zimmer Biomet:


2391 IN RE: Biomet M2a Magnum Hip Implant Products Liability Litigation
Northern District of Indiana (Hon. Robert L. Miller)

A settlement program between was announced in early 2014 in which certain patients implanted with Zimmer Biomet’s defective M2a Magnum hip implant system were to receive up to $200,000. In December, the Court activated a pool of lawsuits as “Group 5” for case-specific discovery. Pursuant to the Court’s order, (i) completed and updated medical records authorizations for the Group 5 cases were to be provided by February 2, 2018, and (ii) the parties may engage in case-specific discovery relating to the Group 5 cases until September 14, 2018. Such discovery may include interrogatories, requests for production, requests for admission, and depositions of (a) the plaintiffs, (b) the implanting surgeon, (c) the revising surgeon, (d) the Zimmer Biomet representative who processed the request for the product used during the implant surgery, (e) any separate Zimmer Biomet representatives who were present in the operating room during the implant or revision surgery, and (f) one additional fact witness per side.

2272 IN RE: Zimmer NexGen Knee Implant Products Liability Litigation
Northern District of Illinois (Hon. Rebecca R. Pallmeyer)

In a January 16th order, Judge Rebecca Pallmeyer of the U.S. District Court for the Northern District of Illinois ruled that Effler, et al. v. Zimmer, Inc., No. 11 C 5489 and Suber v. Zimmer, Inc., 13 C 6806 are appropriate for bellwether trial. Both cases were selected from the 5950 MIS tibial component category. In October 2017, the MDL court had randomly selected 36 cases to constitute the initial pool of cases eligible for trial.

In addition to other case management orders, Judge Pallmeyer issued a Lone Pine order in June 2016 in an attempt to eliminate cases that were making claims other than device defectiveness. The Lone Pine order required claimants to “provide evidence or certification of loosening of a NexGen Flex femoral component, a 5950 NexGen MIS Stemmed tibial component, or any other tibial component implanted with a NexGen Flex femoral component.” Claimants who failed to do so within a certain time frame had their cases dismissed.

In late January 2017, Zimmer won its third bellwether trial. In the first bellwether trial in November 2015, the jury found for Zimmer given that the plaintiff failed to prove defective design and failure to warn claims. Zimmer also won its second bellwether trial in late 2016 on summary judgment when the judge found that the plaintiff failed to prove that a design defect caused the knee implant to fail.

2158 IN RE: Zimmer Durom Hip Cup Products Liability Litigation
District of New Jersey (Hon. Susan D. Wigenton)

In 2016, Zimmer Inc. reached a $314 million binding settlement agreement to resolve claims of patients who underwent revision surgery for a Durom Acetabular Component hip (Durom Cup). Only plaintiffs who had “qualified revision surgery” less than nine years after the date of implantation would be eligible for either a base award of $175,000 subject to enhancement or reduction, or a fixed award of $25,000. The May 2016 MDL court order required that all plaintiffs were required to participate in the settlement process. Those who rejected the offer were required to enter mediation, with a deadline of February 28, 2017 to schedule mediation, and have to wait until the settlement process was complete before taking further legal actions. As of January 2018, there were 257 lawsuits still pending in the MDL.


Zimmer Biomet Comprehensive Reverse Shoulder System Humeral Tray Model 115340

In February 2017, the United States Food & Drug Administration (FDA) released information on a Class 1 recall of Zimmer Biomet‘s Comprehensive Reverse Shoulder System. A Class 1 recall is issued when there is “a reasonable probability that use of these products will cause serious adverse health consequences or death.” Zimmer Biomet’s Comprehensive Reverse Shoulder system is a shoulder replacement device designed to be surgically implanted to restore arm movement in patients with rotator cuff tears who have developed arthropathy and have failed shoulder joint replacements. The reverse shoulder systems were found to have a higher fracture rate than what was indicated on the product’s label, the FDA stated. These fractures would often require patients to undergo revision surgeries, which could cause more damage, including permanent loss of their shoulder function, infection from the implantation surgery, or death. Zimmer Biomet recalled a total of 3,662 devices with product codes KWS and PAO and all lots with part number 115340 manufactured between August 25, 2008 and September 27, 2011, and distributed between October 2008 and September 2015. On December 20, 2016, Zimmer Biomet started sending recall notices for the reverse total shoulder implants and informed the medical community how to quarantine and return the devices affected by the recall.

Other Zimmer News

With a major leadership change made in 2017, Forbes listed Zimmer Biomet as one of “America’s Best Larger Employers of 2017.’ The orthopedic device manufacturer named Bryan Hanson president and CEO in the past year; he comes to Zimmer with a wealth of knowledge from Medtronic to expand the company’s spine portfolio. Zimmer Biomet saw a slight drop in third quarter sales with net earnings totaling $98.8 million due to slow pace recovery in key brands as well as slower-than-anticipated sales recapture in the United States. To further boost sales and growth, Zimmer Biomet launched its Vitality+ and Vital Spinal Fixation Systems, which is the first flexible drill as well as a blunted reamer, in the United States.

#zimmer #biomet #hip #knee #shoulder #implant #recall #lawsuit #productliability

If you or a family member have suffered injury from an orthopedic medical device such as a hip, knee or shoulder implant, or have had revision surgery to remove and replace a hip, knee or shoulder implant, you and/or your family member may be entitled to money damages.

We take your calls and meet with your family personally to answer all your questions. We will press your insurance company for the coverage you are entitled to and help you recover the compensation you deserve. Personal injury cases require a wealth of experience, and a network of proven experts, including doctors and medical experts, accident recreation experts, insurance investigators, private investigators, and the resources necessary to fight large insurance companies.

All of our personal injury cases are contingency cases, which means you pay nothing out of pocket and we do not get paid unless you get paid.

The Ahearne Law Firm, PLLC
Offices in Manhattan and Warwick, New York
Serving New York City, Orange County and the Hudson Valley
Mass tort lawsuits handled nationwide, including the national prescription opiate litigation, Stryker Rejuvenate / ABG II hip implants and LFIT V40 femoral head, DePuy Pinnacle and ASR hip implants, Smith & Nephew BHR hip implant, and ZimmerBiomet Durom Hip Cup and M2A Magnum hip implant
Personal Injury · Product Liability · Medical Malpractice  Commercial Litigation · Criminal Defense · Corporate Counsel Real Estate
For more information, please contact The Ahearne Law Firm, PLLC for an initial consultation and case evaluation. Call nationwide at (845) 986-2777.